@FierceMedDev: FDA plans to clamp down on all-metal hips. Article | Follow @FierceMedDev
@DamianFierce: Big M&A morning: Stryker's ($SYK) spending $764 million on Chinese orthopedics company Trauson. Release | Follow @DamianFierce
> Medtronic ($MDT) has launched a trial to see whether its Reveal Insertable Cardiac Monitor can identify and predict atrial fibrillation in patients at high risk for the disease. More
> Gore is launching a new version of its Q50 Plus Stent Graft Balloon Catheter, a device made to work with aortic stent grafts and treat abdominal aortic aneurysms. Release
> Devicemaker Sanovas has filed for FDA clearance for its Vas Zeppelin Smart Catheter, designed to treat chronic pulmonary diseases and lung cancer. News
> Back in 2009, when NuVasive ($NUVA) acquired Cervitech, it agreed to pay out milestones when the company's device got FDA approval. Now, a Cervitech investor is suing, saying he never got his cut. Story
> Drug delivery specialist pSivida ($PSDV) is expanding the use of its back-of-the-eye delivery device, as Iluvien, a drug that uses the tech, got market approval in Spain. Item
> Covidien ($COV) is partnering with the NFL Players Association and the Living Heart Foundation to launch the HOPE Program, designed to promote healthy lifestyles for former NFL athletes. Release
Biotech News
@FierceBiotech: Popular yesterday : Buzz: $AZN reorg inspires fresh rumors of $SHPG bid. Report | Follow @FierceBiotech
@JohnCFierce: Columnist gushes over Inovio's Kim, a tireless promoter whose stock is trading at .67 and whose flu vax is in PhI. Column | Follow @JohnCFierce
@RyanMFierce: $EXEL's plethora of partnerships bearing fruit as Genentech moves melanoma drug from EXEL into PhIII. More | Follow @RyanMFierce
> FDA green-lights a flu vaccine made with new technology. Story
> Genentech launches PhIII for melanoma combo with GSK in hot pursuit. Article
> AstraZeneca shakeup pushes research chief to top of restructured MedImmune. News
Pharma News
@FiercePharma: Bond market pants for Pfizer vet unit's debut offering: Zoetis sets up $3.65B in debt amid final prep for IPO. More | Follow @FiercePharma
@AlisonBFierce: FierceVaccines brings you the major FDA vaccine approvals from 2012. Special Report | Follow @AlisonBFierce
> Aranesp flunks heart-failure trial, raising new questions about use. News
> MedImmune unit split 3 ways in AstraZeneca shake-up. More
> AARP, AFL-CIO and prominent docs to White House: Get us the sunshine rules, stat. Story
Vaccines News
> IOM confirms safety of childhood vaccine schedule. Report
> CDC: Flu hits epidemic level in U.S. Item
> Protein Sciences nabs Flublok approval. News
> Vaccine stakes upped as dengue dubbed fastest-spreading tropical disease. Article
> Flu vaccine, Tamiflu shortage as influenza sweeps U.S. Story
Pharma Manufacturing News
@EricPFierce: Amgen to build $200 million monoclonal antibody plant in Singapore. Novartis building there too. More | Follow @EricPFierce
> Wisconsin report adds to drug take-back funding debate. Item
> China ups bounty for tips on counterfeiters to $48,500. Report
> Japan's Mitsui ups stake in India API maker Arch. Story
> FDA spells out user fees for generic drugs. Article
> J&J consent decree cost felt at the pharmacy. More